Letter

Funding of contraceptive implants is crucial

BMJ 1997; 314 doi: 10.1136/bmj.314.7082.750 (Published 8 March 1997)
Cite this as: BMJ 1997;314:750.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Lawrence Mascarenhas, Subspecialty senior registrar in reproductive medicinea,
  2. Yakoub Khalaf, Senior registrar in obstetrics and gynaecologyb,
  3. Sammy Lee, Scientistc
  1. a Rosie Maternity Hospital, Cambridge CB2 2SW
  2. b Guy's and St Thomas's Hospital, London SE1 9RT
  3. c Portland Hospital, London W1N 6AH

    Editor—M S Thompson's argument that the greatest problem with contraceptive implants is their potential to increase providers' control over clients' choice does not stand up to scrutiny.1 Implants form part of a range of long acting reversible contraceptives, which include intrauterine contraceptive devices, the intrauterine contraceptive …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular